Yield10 Bioscience, Inc. (YTEN) Tops Q3 EPS by 16c

Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.49), $0.16 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $92 thousand versus the consensus estimate of $210 thousand.

For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Macquarie cuts Macau gaming sector forecasts on weak GGR growth
• Caterpillar (CAT) PT Raised to $1,105 at Oppenheimer